Literature DB >> 30746193

Prognostic value of tumor solid-part size and solid-part volume in patients with clinical stage I non-small cell lung cancer.

Yoshihisa Shimada1, Hideyuki Furumoto1, Kentaro Imai1, Ryuhei Masuno2, Jun Matsubayashi3, Naohiro Kajiwara1, Tatsuo Ohira1, Norihiko Ikeda1.   

Abstract

BACKGROUND: This study aimed to predict the malignant potential of clinical stage I non-small cell lung cancer (c-I NSCLC) by semiautomatic three-dimensional (3D) volumetric measurement of a tumor (3D-data) and the axial computed tomography (CT) data derived from a 3D volumetric dataset (2D-data). The predictive performance was evaluated in terms of overall survival (OS), disease-free survival (DFS), and pathological invasive factors (positive lymphatic invasion, blood vessel invasion, pleural invasion, or lymph node metastasis).
METHODS: We identified 252 patients (122 male; mean age, 68 years; range, 23-84 years) with c-I NSCLC who underwent high resolution CT and reconstruction of 3D imaging, followed by complete resection between January 2012 and December 2015. In this study, 2D-data including whole tumor size (WTS) and solid-part size (SPS) and 3D-data including whole tumor volume (WTV) and solid-part volume (SPV) acquired by a 3D volume rendering software were analyzed.
RESULTS: The area under the receiver operating characteristic (ROC) curve for WTS, SPS, WTV, SPV relevant to recurrence was 0.667, 0.727, 0.654, and 0.751 while analyses of ROC curves revealed optimal WTS, SPS, WTV, and SPV cut-off values to predict recurrence of 2.48 cm, 2.03 cm, 3,258 mm3 and 1,889 mm3, respectively. The association between SPS and SPV was the coefficient of determination (R 2) =0.59. Multivariate analysis showed that SPV >1,889 mm3 (P=0.016) and male (P=0.041) were significant predictors of OS whereas SPV >1,889 mm3 (P=0.001), male (P=0.003), and the serum carcinoembryonic antigen value (P=0.041) were significantly correlated with DFS. SPS, SPV as well as the combination of SPS and SPV were all significantly correlated with the prediction of OS and DFS, and the incidence of pathological invasive factors.
CONCLUSIONS: SPV and the integrated use of SPS and SPV was highly beneficial for the prediction of postoperative prognosis in c-I NSCLC.

Entities:  

Keywords:  Non-small cell lung cancer (NSCLC); solid-part; stage I; three-dimensional CT (3DCT); volume

Year:  2018        PMID: 30746193      PMCID: PMC6344704          DOI: 10.21037/jtd.2018.11.08

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  21 in total

1.  The role of computed tomographic scanning in diagnosing mediastinal node involvement in non-small cell lung cancer.

Authors:  K Takamochi; K Nagai; J Yoshida; K Suzuki; Y Ohde; M Nishimura; K Takahashi; Y Nishiwaki
Journal:  J Thorac Cardiovasc Surg       Date:  2000-06       Impact factor: 5.209

2.  Prognostic impact of intratumoral vascular invasion in non-small cell lung cancer patients.

Authors:  Ryo Maeda; Junji Yoshida; Genichiro Ishii; Tomoyuki Hishida; Mitsuyo Nishimura; Kanji Nagai
Journal:  Thorax       Date:  2010-10-22       Impact factor: 9.139

Review 3.  Minimally invasive approach to early, peripheral adenocarcinoma with ground-glass opacity appearance.

Authors:  Hisao Asamura
Journal:  Ann Thorac Surg       Date:  2008-02       Impact factor: 4.330

Review 4.  Three dimensional computed tomography lung modeling is useful in simulation and navigation of lung cancer surgery.

Authors:  Norihiko Ikeda; Akinobu Yoshimura; Masaru Hagiwara; Soichi Akata; Hisashi Saji
Journal:  Ann Thorac Cardiovasc Surg       Date:  2013-01-31       Impact factor: 1.520

5.  Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.

Authors:  Yasuhiro Tsutani; Yoshihiro Miyata; Haruhiko Nakayama; Sakae Okumura; Shuji Adachi; Masahiro Yoshimura; Morihito Okada
Journal:  J Thorac Cardiovasc Surg       Date:  2011-11-20       Impact factor: 5.209

6.  A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201).

Authors:  Kenji Suzuki; Teruaki Koike; Takashi Asakawa; Masahiko Kusumoto; Hisao Asamura; Kanji Nagai; Hirohito Tada; Tetsuya Mitsudomi; Masahiro Tsuboi; Taro Shibata; Haruhiko Fukuda; Harubumi Kato
Journal:  J Thorac Oncol       Date:  2011-04       Impact factor: 15.609

7.  Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.

Authors:  Yoshihisa Shimada; Hisashi Saji; Koichi Yoshida; Masatoshi Kakihana; Hidetoshi Honda; Masaharu Nomura; Jitsuo Usuda; Naohiro Kajiwara; Tatsuo Ohira; Norihiko Ikeda
Journal:  J Thorac Oncol       Date:  2012-08       Impact factor: 15.609

8.  Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis.

Authors:  Haruhisa Matsuguma; Kohei Yokoi; Masaki Anraku; Tetsuro Kondo; Yukari Kamiyama; Kiyoshi Mori; Keigo Tominaga; Yukio Tsuura; Satoshi Honjo
Journal:  J Thorac Cardiovasc Surg       Date:  2002-08       Impact factor: 5.209

9.  Discrepancy of computed tomographic image between lung and mediastinal windows as a prognostic implication in small lung adenocarcinoma.

Authors:  Morihito Okada; Wataru Nishio; Toshihiko Sakamoto; Kazuya Uchino; Noriaki Tsubota
Journal:  Ann Thorac Surg       Date:  2003-12       Impact factor: 4.330

10.  Visceral pleural invasion classification in non-small-cell lung cancer in the 7th edition of the tumor, node, metastasis classification for lung cancer: validation analysis based on a large-scale nationwide database.

Authors:  Akikazu Kawase; Junji Yoshida; Etsuo Miyaoka; Hisao Asamura; Yoshitaka Fujii; Yoichi Nakanishi; Kenji Eguchi; Masaki Mori; Noriyoshi Sawabata; Meinoshin Okumura; Kohei Yokoi
Journal:  J Thorac Oncol       Date:  2013-05       Impact factor: 15.609

View more
  3 in total

1.  Selecting therapy for small ground-glass tumors-the potential role of volumetric computed tomography scan.

Authors:  Xiangwen Wu; Hiran C Fernando
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

2.  Prognostic impact of solid tumor component diameter in early-stage non-small cell lung carcinoma treated with intensity-modulated fractionated radiotherapy: a retrospective analysis impact of solid tumor component diameter in NSCLC treated with IMRT.

Authors:  Tomohiro Itonaga; Ryuji Mikami; Mitsuru Okubo; Tatsuhiko Saito; Sachika Shiraishi; Shinji Sugahara; Koichi Tokuuye; Kazuhiro Saito
Journal:  Br J Radiol       Date:  2020-03-03       Impact factor: 3.039

3.  The utility of three-dimensional computed tomography for prediction of tumor invasiveness in clinical stage IA lung adenocarcinoma.

Authors:  Yohei Kawaguchi; Masayuki Nakao; Kenshiro Omura; Naoya Iwamoto; Hiroki Ozawa; Yasuto Kondo; Junji Ichinose; Yosuke Matsuura; Sakae Okumura; Mingyon Mun
Journal:  J Thorac Dis       Date:  2020-12       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.